{"name":"Nereus Pharmaceuticals, Inc.","slug":"nereus-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NPI-2358","genericName":"NPI-2358","slug":"npi-2358","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"NPI-2358","genericName":"NPI-2358","slug":"npi-2358","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNZjd3dENhMmJuQW5PdDBnRXl6dnVxbThpNmZkTTg5WkxEbjVkRDZPTTNvbzBoS20xWGFHdWVCaUd4M1NvZ2NpYkY1N3p3Vnk4bFNxVUxEdG5xakp3U1ppV1pYcWFMUy1iQ1lvLTFtem8tTjRoMUxOZ2kwS1lHQl9tNXFBbTBkZFo3bHdzNmVrRDlKSFA1eFgtWFRMR1lMNkVVRWFyZVBGOGQ5RllYYXlISFludHI4TGtaX3lZSmlB?oc=5","date":"2026-02-12","type":"earnings","source":"BioSpace","summary":"Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - BioSpace","headline":"Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOMHVrenBVVEpuTWhzUXFkdTgtb3R3dEUyZTZ1dVpydks5Vjg1LXpMTVRnSXdHUzRmbm8yb2wyYUlyU0dHR1cwWXU2ZzF0bkpDcmZsbjNOTGQwN0ZvcHctWWlPRWlWTDNqREtCMjRJMmhReElCQ0h6N2RhbXZwMl9iVkNER1VGNm1TemxkWThMY0psMkM4cngxemg3d1dib1pHVkRQZWRYWQ?oc=5","date":"2026-01-01","type":"pipeline","source":"seekingalpha.com","summary":"Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus (NASDAQ:VNDA) - seekingalpha.com","headline":"Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus (NASDAQ:VNDA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeWxEbUQteG1qVHJSNHV0bVJfNFhvRm41UVRFcG4tN1FzdGJqbVJUYm4wS3VxMzV1bXBPamNleXRlT01VNGpXb1RtZVdGRDJSbFNqQkgtOTVhSWdsQ0lSYkx5THZ1T3p4TGNidm5YWEU2dkVrZXdKRV9wYjhCdFNrWks2WHlXdkpwYnJuNEh0bmphdHU4Y1RHc0tyQjdjdmRGUEFyWl8zUDg?oc=5","date":"2025-12-31","type":"regulatory","source":"Barron's","summary":"Vanda Pharmaceuticals Stock Jumps After FDA Approves Motion Sickness Drug - Barron's","headline":"Vanda Pharmaceuticals Stock Jumps After FDA Approves Motion Sickness Drug - Barron's","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOcFpsM3VEQXlTdkFVR2F3b2xYb21VcjBZc1JOb1BoSkZOUEpSNzF6Vl9OX1pjX3NiRVZkYjhScGNZYmJ6YnpqUTR5V2VtaFVNUWV5dTRfcTFaeGhXQnJUWVhhUjdTLUtlckxzeUJnaS1KLTRLVVJBdU91WEVadDJZS1lRdTQ2ckpTWDM2MkxpYmVSbThfTmVTU2g4VEY3N2JkS2c?oc=5","date":"2025-12-31","type":"regulatory","source":"BioWorld News","summary":"Vanda stock jumps with FDA approval of motion sickness drug - BioWorld News","headline":"Vanda stock jumps with FDA approval of motion sickness drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQS3FIRlV2SEVEbENWOVdHYUt4dkJ4SklUWmpuWldFcS1ydW1PX0FyUkp3eGZoYk5tR1FGT2RJODNNNVNYQkg5TTlDSXp0WTNRdVl6VTFmU0FINDZ3QWdkYUZpaE5yemZQZk1Dd1Q1dWl6UGRuREpRWF9qRm9teXZlZ1NmMndndXhyWDVFVmFzRTRHZXhnWDRBTk9kTWZWNUs0UjRqYXNzT3gxUUdZUHNNS1lkS3JOSEF3R1hMeFFwTEg3VUt3UE1DRmNaRXM?oc=5","date":"2025-12-31","type":"regulatory","source":"TechStock²","summary":"Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades - TechStock²","headline":"Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades - TechS","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOMnM0QjRKNEFIMmNpYnNkSlFxNjlURUJxSjdQT3NDRi02UEJpSjlwZTgtR25JUWdyeEZnQzY4Q0xxenIwN2s5LXhETmhETVRuMl9Damk2dDJDdlB2QkY2dHVmOXJjU3BtcDBfeXY1cU5Nck1GQzdtNnY2NG1EdFRfb2FUSUtMZFVjUkhwUlFmX1ltWTlSNVlRUThKTkVnNTZRc003S0QzOGtta0x6Zm9VQmIwTDJsc3JCd3hNbFEtYWp0anJicDlDRU13?oc=5","date":"2025-12-31","type":"regulatory","source":"Reuters","summary":"US FDA approves Vanda Pharmaceuticals' motion sickness drug - Reuters","headline":"US FDA approves Vanda Pharmaceuticals' motion sickness drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxQaHlyS0hnMDhSVkNUcTVQM0RTbGx0eF9tU1ZVdFpvenRtOUw4clgtQ2JvMHMtOGwxb1NuUHhGUEp4TWRwWElZU1pWWTdGNWlFZzJJeFplQzluaVg5WTVKMk52TVk4QlN3UWJMYlNUaXV0V0tDRkZGb01zaHM5UnB4WE1MRE8zYXljZFIydHNYR1JQd0gwTGZRQXlzVmZaSHVsRVppRUdXWF93bkxLdkRNY0FLX1M0N2VkdGhTLWt5MXZpek5vTGJ1dGVYZ3dnSjFxbDVRYXpNcFlqN1N5Vy1lYzV2U0xsS2N5bkZselpaOVRZbUY0OVdJNkJSa0JHczNaNG9CaGZUaXlIRzdVLXI5VXhKeE5mRHloc2tVX2JGNHNjcEpZT0pBNnVFZlVkOXcySXNNeGtHbjhQbTNGVElHN1BfMDE4RXdvUzFsMVRzNDV6Tld4Tm93OFBoQ0I?oc=5","date":"2025-12-30","type":"regulatory","source":"prnewswire.com","summary":"Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness - prnewswir","headline":"Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: ","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-11-13","type":"regulatory","source":"Medical Dialogues","summary":"Alembic Pharma bags USFDA nod for erosive esophagitis drug Dexlansoprazole Delayed Release - Medical Dialogues","headline":"Alembic Pharma bags USFDA nod for erosive esophagitis drug Dexlansoprazole Delayed Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1xNlBhN3BCR2d4QnpRMWltVG9xdF9KM01mazJ6SnBqR1FvTEFuZ1d0M1dTajZrZ1o5RXF0Zl9JVzN6NExtTjYxV21QLUJIM0E3d1Bz?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"VNDA Stock Price, News & Analysis | Vanda Pharma - Stock Titan","headline":"VNDA Stock Price, News & Analysis | Vanda Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}